The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension.
Simpson CE, Griffiths M, Yang J, Nies MK, Vaidya RD, Brandal S, Martin LJ, Pauciulo MW, Lutz KA, Coleman AW, Austin ED, Ivy DD, Nichols WC, Everett AD, Hassoun PM, Damico RL.
Simpson CE, et al. Among authors: nies mk.
ERJ Open Res. 2021 Oct 11;7(4):00378-2021. doi: 10.1183/23120541.00378-2021. eCollection 2021 Oct.
ERJ Open Res. 2021.
PMID: 34651041
Free PMC article.